THE REAL-WORLD EFFICACY AND SAFETY OF VEDOLIZUMAB IN BIO-NAïVE PATIENTS WITH INFLAMMATORY BOWEL DISEASE - AN INTERIM ANALYSIS FROM A DANISH NATIONAL COHORT STUDY

Mohamed Attauabi  ¹     Janne Ladefoged Fassov  ²     Signe Wildt  ³     Michael Dam Jensen  ⁴     jens kjeldsen  ⁵     Ana Maria Popa  ⁶     Henrik Albæk Jacobsen  ⁷     Kenneth Bo Pedersen  ⁸     Cecilie Lind  ⁹     Natalia Pedersen  ¹⁰     Kent Valentin Haderslev  ¹¹     akbar molazahi  ¹²     Jakob Benedict Seidelin  ¹³     Johan Burisch  ^13    
1 Hvidovre University Hospital, Hvidovre, Denmark
² Aarhus University Hospital, Aarhus, Denmark
³ Koege University Hospital, Koege, Denmark
⁴ Lillebaelt Hospital Vejle, Vejle, Denmark
⁵ Odense University Hospital, Odense, Denmark
⁶ Nykoebing Falster Hospital, Nykoebing Falster, Denmark
⁷ Aalborg University Hospital, Aalborg, Denmark
⁸ Hospital of Southwest Jutland, Esbjerg, Denmark
⁹ Regional Hospital West Jutland Viborg, Viborg, Denmark
¹⁰ Slagelse Hospital, Slagelse, Denmark
¹¹ Rigshospitalet, Copenhagen, Denmark
¹² Holbaek Hospital, Holbaek, Denmark
¹³ Herlev University Hospital, Herlev, Denmark

Session
IBD (Posters)

Conference
UEG Week Virtual 2020

Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)